Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lloyd Marcea Bland
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schmid John P.
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Collins Cynthia
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Corning Luke
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAUM CHARLES M
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Amado Rafael
Poseida Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.97%)
Poseida Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis Pharma AG(0%),Novartis AG(0%)
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rizvi Syed Ali-aamir
Poseida Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Rizvi Syed Ali-aamir
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mylet Johanna
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEONHARDT HARRY J
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gergen Mark J
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warner Brent
Poseida Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gergen Mark J
Poseida Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.3%)
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yarema Kristin
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gergen Mark J
Poseida Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Astellas Pharma Inc.(8.7%),Astellas US Holding, Inc.(8.7%), etc.
No Data